Status: Not yet recruiting
Study to Determine Efficacy, Safety, and Tolerability of B244 as a Topical Spray in Subjects With Moderate to Severe Acne Vulgaris
This is a phase 2b, randomized, double-blind, vehicle-controlled clinical trial evaluating the efficacy, safety, and tolerability of B244 compared to vehicle in the treatment of moderate to severe acne vulgaris in adolescents and adults. Participants who meet the study entry criteria will be randomized in a 1:1 ratio to receive twice daily topical doses of B244 O.D. 5.0 or vehicle (control) for 12 weeks.
Participants needed: 176
Trial details
Phase: Phase 2Age: 12+Biological sex: AllType: InterventionalSponsor: AOBiome LLCUpdated: Oct 8, 2026
Eligibility criteria
Males and females age 12 years and older [+10]
Use of topical acne treatments, including benzoyl peroxide within 2 weeks prior... [+30]